Viewing StudyNCT00004829



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004829
Status: COMPLETED
Last Update Posted: 2015-03-25
First Post: 2000-02-24

Brief Title: Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
Sponsor: FDA Office of Orphan Products Development
Organization: FDA Office of Orphan Products Development

Organization Data

Organization: FDA Office of Orphan Products Development
Class: FED
Study ID: 19913390
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: FDA Office of Orphan Products Development
Lead Sponsor Class: FED
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators